TMCI
Treace Medical Concepts, Inc.
$4.21
-0.02 (-0.47%)
At close · Jul 2
Market Cap
$273.12M
Shares
64,872,976
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.21
Open$4.29
Day$4.11–4.43
52W$1.17–7.78
Avg vol 30d975K
Short int3.3M · 5.0% float · 4.5d
Short vol36%
Last earningsApr 9, 2026
DataApr 2021–Jul 2026
Filing10-Q · May 8
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+29% above
+
Price vs 50-day avg
+36% above
◦
RSI (14)
58 · neutral
−
MACD trend
negative
◦
52-week position
46% · mid-range
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $3 › 200d $3 — 200d above 50d
+
Institutional flow
+2% holders QoQ · +31 funds added
+
Insider flow
Net +$1.1M over 90 days · 0% sells
+
Short interest
5.04% of float · ▼ -20.4% MoM · 4.5 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
117 holders — near 3-yr low, contrarian setup
Fundamentals
Weak
◦
Revenue growth
+2% Y/Y
+
Gross margin
80%, contracting
−
EPS growth
−3% Y/Y
−
Free cash flow
$-29.5M
−
Balance sheet
net debt $44.9M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Jul 9, 2026
Est · unconfirmed
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 8, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance & track record
Latest guidance
· from the 8-K filed May 8, 2026
full-year 2026
Revenue
Initiated
$202M – $212M
prior FY $212.69M
midpoint −2.7% Y/Y
Cash usage
Initiated
up to 50%
full year 2026
Adjusted EBITDA
Non-GAAP
Initiated
$-6M – $-4M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+29% above
Bullish
Price vs 50-day avg
+36% above
Bullish
RSI (14)
58 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
46% · mid-range
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+2% holders QoQ · +31 funds added
Insider flow
Accumulating
Net +$1.1M over 90 days · 0% sells
Short interest
Falling
5.04% of float · ▼ -20.4% MoM · 4.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
117 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $1
Now $4 · 46%
52-wk high $8
vs 200-day avg +29%
vs 50-day avg +36%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cash, cash equivalents, and marketable securities | $51.9M | as of March 31, 2026 | — |
| Active surgeons | 3,337 | full-year 2025 | — |
| Adjusted EBITDA non-GAAP | $6.2M | fourth quarter 2025 | — |
| Cash usage | $27.3M | full-year 2025 | — |
| Granted patents | 135 | full-year 2025 | — |
| Net new active surgeons | 202 | full-year 2025 | — |
| Pending patent applications | 199 | full-year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TMCI
this stock
Treace Medical Concepts, Inc.
|
$273.12M | +71.8% | +1.6% | — | 5.0% |
|
ABT
Abbott Laboratories
|
$166.17B | -23.5% | +5.7% | 26.7 | 1.3% |
|
SYK
Stryker Corp
|
$125.18B | -6.8% | +11.2% | 37.8 | 1.6% |
|
MDT
Medtronic plc
|
$106.49B | -12.7% | +8.4% | 22.3 | 1.4% |
|
BSX
Boston Scientific Corp
|
$67.09B | -52.7% | +5.5% | 18.9 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TMCI | -5.4% | +23.8% | +42.2% | +5.8% | +71.8% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -6.8% | +25.1% | +34.2% | +6.1% | +62.6% |